Discuss the data presented at the European Hematology Association 2024 (EHA 2024) Hybrid Congress on minimal residual disease (MRD) in the PERSEUS trial of daratumumab plus bortezomib ...
The latest research on the treatment of patients with myelofibrosis (MF) presented at the European Hematology Association (EHA) 2024 annual meeting is reported on by Dr Alessandro Maria Vannucchi ...
The late-breaking oral session at the European Hematology Association (EHA) 2024 Congress featured new data from abstracts submitted after the deadline, including both interventional and ...
Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or window Visit us on TikTok. Opens in a new tab or window ...
The phase 1/2 trial presented at EHA tested SAR443579 as a monotherapy for the treatment of a basket of blood cancers with high unmet needs, including relapsed or refractory acute myeloid ...
“This order works to establish a new paradigm for water resource management and collaboration in Na Wai ‘Eha,” said Kamanamaikalani Beamer, who left the water commission following the Na Wai ...
During the basic science morning track on the last day of this year’s Annual Congress of the European Hematology Association (EHA), the attention was focused on oncogenic transcription factors and ...
et al "Glofitamab plus gemcitabine and oxaliplatin for relapsed/refractory diffuse large B-cell lymphoma: results of a global randomized phase III trial (STARGLO)" EHA 2024; Abstract LB3438.
The results, presented at the annual European Hematology Association (EHA) Congress, confirm the transformative, consistent and durable clinical benefits of CASGEVY over time. CASGEVY is the first ...
Professor Gribben accepted the award at the EHA's Annual Congress in Spain last month, where he presented a lecture entitled: “The impact of hematologic malignancies on the host immune system”. The ...
THE HAGUE, Netherlands, July 15, 2024 /PRNewswire/ -- The European Hematology Association (EHA) has undergone a remarkable transformation over the past two years, positioning itself as a future ...